Greyson Biegert to Cell Line, Tumor
This is a "connection" page, showing publications Greyson Biegert has written about Cell Line, Tumor.
Connection Strength
0.035
-
Additional expression of T-cell engager in clinically tested oncolytic adeno-immunotherapy redirects tumor-infiltrated, irrelevant T cells against cancer cells to enhance antitumor immunity. J Immunother Cancer. 2024 Dec 09; 12(12).
Score: 0.035